Interestingly, our findings showed that CREB3L1 expression was abnormally decreased in BLCA, and CREB3L1 expression was increased during tumor stage progression in patients with BLCA, which seems to be contradictory. This evidence concerns the gene CREB3L1 and neoplasm.